MwanzoMESO • NASDAQ
add
Mesoblast Ltd
Bei iliyotangulia
$ 10.18
Bei za siku
$ 9.89 - $ 10.27
Bei za mwaka
$ 1.61 - $ 12.18
Thamani ya kampuni katika soko
1.10B USD
Wastani wa hisa zilizouzwa
elfu 199.96
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.26M | -41.23% |
Matumizi ya uendeshaji wa biashara | 6.11M | 5.44% |
Mapato halisi | -27.71M | -26.41% |
Kiwango cha faida halisi | elfu -2.20 | -115.11% |
Mapato kwa kila hisa | — | — |
EBITDA | -15.26M | 17.72% |
Asilimia ya kodi ya mapato | 0.16% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 62.96M | -11.72% |
Jumla ya mali | 669.15M | -0.04% |
Jumla ya dhima | 188.80M | 12.66% |
Jumla ya hisa | 480.36M | — |
hisa zilizosalia | 1.14B | — |
Uwiano wa bei na thamani | 24.24 | — |
Faida inayotokana na mali | -5.86% | — |
Faida inayotokana mtaji | -6.55% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -27.71M | -26.41% |
Pesa kutokana na shughuli | -10.94M | 32.77% |
Pesa kutokana na uwekezaji | elfu -4.50 | -128.12% |
Pesa kutokana na ufadhili | 4.33M | -88.84% |
Mabadiliko halisi ya pesa taslimu | -7.30M | -132.40% |
Mtiririko huru wa pesa | -10.19M | 53.48% |
Kuhusu
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2004
Tovuti
Wafanyakazi
73
